German (DAX) Life Sciences Industry Analysis

Industry Valuation and Performance

Has the German Life Sciences Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Fri, 07 Feb 2025	€23.6b	€7.1b	€169.8m	24.1x	139x	3.3x
Sun, 05 Jan 2025	€20.8b	€7.1b	€169.8m	24.5x	122.2x	2.9x
Tue, 03 Dec 2024	€22.1b	€7.1b	€170.5m	27x	129.7x	3.1x
Thu, 31 Oct 2024	€23.2b	€7.1b	€171.2m	30.2x	135.3x	3.3x
Sat, 28 Sep 2024	€24.9b	€7.1b	€172.8m	31.1x	144.2x	3.5x
Mon, 26 Aug 2024	€23.8b	€7.0b	€157.1m	34.2x	151.6x	3.4x
Wed, 24 Jul 2024	€23.7b	€7.0b	€237.1m	36.3x	100x	3.4x
Fri, 21 Jun 2024	€22.5b	€7.0b	€333.3m	28.5x	67.5x	3.2x
Sun, 19 May 2024	€26.6b	€7.0b	€340.1m	30x	78.2x	3.8x
Tue, 16 Apr 2024	€32.6b	€7.1b	€385.4m	36.8x	84.5x	4.6x
Thu, 14 Mar 2024	€33.8b	€7.1b	€384.5m	37.7x	87.9x	4.8x
Sat, 10 Feb 2024	€32.6b	€7.3b	€516.3m	38.1x	63.2x	4.5x
Mon, 08 Jan 2024	€30.8b	€7.3b	€507.1m	34.8x	60.7x	4.2x
Wed, 06 Dec 2023	€28.0b	€7.3b	€507.1m	30.4x	55.2x	3.8x
Fri, 03 Nov 2023	€25.7b	€6.4b	€356.1m	38.3x	72.1x	4x
Sun, 01 Oct 2023	€26.8b	€6.6b	€498.1m	38.3x	53.8x	4.1x
Tue, 29 Aug 2023	€29.5b	€6.6b	€425.8m	43x	69.3x	4.5x
Thu, 27 Jul 2023	€30.1b	€6.6b	€425.8m	42.1x	70.7x	4.6x
Sat, 24 Jun 2023	€26.8b	€6.7b	€487.3m	38x	55.1x	4x
Mon, 22 May 2023	€28.1b	€6.7b	€487.3m	38.6x	57.7x	4.2x
Wed, 19 Apr 2023	€30.3b	€6.8b	€595.6m	34.2x	50.8x	4.5x
Fri, 17 Mar 2023	€30.4b	€6.7b	€594.3m	34.7x	51.2x	4.5x
Sun, 12 Feb 2023	€32.5b	€6.5b	€447.4m	40.4x	72.7x	5x
Tue, 10 Jan 2023	€29.9b	€6.5b	€447.4m	36.6x	66.9x	4.6x
Thu, 08 Dec 2022	€27.7b	€6.5b	€447.4m	33.3x	61.9x	4.3x
Sat, 05 Nov 2022	€26.7b	€6.4b	€629.0m	43x	42.4x	4.1x
Mon, 03 Oct 2022	€27.5b	€6.2b	€573.0m	50x	48.1x	4.4x
Wed, 31 Aug 2022	€5.6b	€2.3b	€84.0m	1241.7x	67.1x	2.4x
Fri, 29 Jul 2022	€6.4b	€2.3b	€171.9m	36.3x	37x	2.8x
Sun, 26 Jun 2022	€6.4b	€2.2b	€173.3m	36.3x	37x	2.9x
Tue, 24 May 2022	€6.6b	€2.2b	€173.3m	37.1x	37.9x	3x
Thu, 21 Apr 2022	€6.9b	€2.2b	€299.3m	23.8x	23x	3.1x
Sat, 19 Mar 2022	€7.2b	€2.1b	€342.9m	19.9x	21.1x	3.5x
Mon, 14 Feb 2022	€7.7b	€2.0b	€345.6m	20.1x	22.1x	3.7x

Current Industry PE

Investors are optimistic on the German Life Sciences industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 140x which is higher than its 3-year average PE of 70.6x.

The 3-year average PS ratio of 3.8x is higher than the industry's current PS ratio of 3.4x.

Past Earnings Growth

The earnings for companies in the Life Sciences industry have declined 21% per year over the last three years.
Meanwhile revenues for these companies have grown 51% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the German Healthcare industry?


DE Market	0.49%
Healthcare	-1.76%
Life Sciences	-5.32%
Clinical Research and Equipment	-5.32%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Company	Last Price	7D	1Y	Valuation
GXI Gerresheimer	€72.35	6.6% +€153.7m	-17.1%	PE21.9x
EVT Evotec	€9.03	5.2% +€79.8m	-36.2%	PS2.1x
991 Vitruvia Medical	€1.60	23.1% +€693.2k	300.0%	PS2.1x

Company

Last Price

Valuation

GXI Gerresheimer

€72.35

6.6%
+€153.7m

-17.1%

PE21.9x

EVT Evotec

€9.03

5.2%
+€79.8m

-36.2%